Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023
DOI: 10.32947/ajps.v23i2.1013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al Mustansiriyah Journal of Pharmaceutical Sciences, 2023. Verfasst von Ghufran salah ahmed und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic.
Objective
The study aimed to determine the efficacy of (5 and 10) mg of olanzapine with antiemetic drugs against chemotherapy-induced nausea and vomiting.
Methods
The study groups are Group S: received triple antiemetic therapy aprepitant at (1-3) day, dexamethasone at (1-4) day, and ondansetron only on the first day. Group O5: received olanzapine 5 mg with triple antiemetic therapy aprepitant (1-3) days, dexamethasone (1-4) day, ondansetron the first day, and olanzapine 5 mg (1-4) days. Group O10: received (olanzapine 10 mg with triple antiemetic therapy) aprepitant (1-3) days, dexamethasone (1-4) days, ondansetron day 1, and olanzapine 10 mg (1-4) days. The cancer was diagnosed by mamograph; the MAT score was used to control chemotherapy-caused nausea and vomiting.
Results
Higher acute and delayed nausea was observed in group S than in groups O5 and O10. Overall, nausea control was increased in group S than in groups O5 and O10. There was no significant difference between the different study groups.
Conclusion
Olanzapine 5 mg and 10 mg could treat nausea more than triple antiemetic in patients with nausea.
Zitieren
APA
ahmed, G. S., khadim2, K. A., & talib, N. M. (2023). Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. https://doi.org/10.32947/ajps.v23i2.1013
Vancouver
ahmed GS, khadim2 KA, talib NM. Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2023. doi:10.32947/ajps.v23i2.1013
BibTeX
@article{ahmed2023,
author = {ahmed, Ghufran salah and khadim2, Khadim ali and talib, Nabeel mudheher},
title = {Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients},
journal = {Al Mustansiriyah Journal of Pharmaceutical Sciences},
year = {2023},
doi = {10.32947/ajps.v23i2.1013}
}
EUVIMED